NASDAQ:PTGX | Insider Transactions — Page 2 | Protagonist Therapeutics, Inc

PTGX Insider Transactions — Page 2

153 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 101–153; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
CANAAN X L.P.TenPercentOwner2018-05-17Sale38,968.0$6.09
Canaan Partners X LLCTenPercentOwner2018-05-17Sale38,968.0$6.09
CANAAN X L.P.TenPercentOwner2018-05-16Sale29,441.0$6.46
Canaan Partners X LLCTenPercentOwner2018-05-16Sale29,441.0$6.46
CANAAN X L.P.TenPercentOwner2018-05-15Sale57,715.0$6.48
Canaan Partners X LLCTenPercentOwner2018-05-15Sale57,715.0$6.48
CANAAN X L.P.TenPercentOwner2018-05-14Sale77,591.0$6.37
Canaan Partners X LLCTenPercentOwner2018-05-14Sale77,591.0$6.37
CANAAN X L.P.TenPercentOwner2018-03-23Sale59,950.0$20.71
Canaan Partners X LLCTenPercentOwner2018-03-23Sale59,950.0$20.71
CANAAN X L.P.TenPercentOwner2018-03-22Sale4,759.0$20.62
Canaan Partners X LLCTenPercentOwner2018-03-22Sale4,759.0$20.62
CANAAN X L.P.TenPercentOwner2018-03-21Sale17,699.0$20.61
Canaan Partners X LLCTenPercentOwner2018-03-21Sale17,699.0$20.61
CANAAN X L.P.TenPercentOwner2018-03-20Sale17,060.0$20.61
Canaan Partners X LLCTenPercentOwner2018-03-20Sale17,060.0$20.61
CANAAN X L.P.TenPercentOwner2018-03-19Sale13,439.0$20.57
Canaan Partners X LLCTenPercentOwner2018-03-19Sale13,439.0$20.57
CANAAN X L.P.TenPercentOwner2018-03-16Sale6,926.0$20.51
Canaan Partners X LLCTenPercentOwner2018-03-16Sale6,926.0$20.51
CANAAN X L.P.TenPercentOwner2018-03-15Sale11,751.0$20.64
Canaan Partners X LLCTenPercentOwner2018-03-15Sale11,751.0$20.64
CANAAN X L.P.TenPercentOwner2018-03-14Sale200.0$20.77
Canaan Partners X LLCTenPercentOwner2018-03-14Sale200.0$20.77
CANAAN X L.P.TenPercentOwner2018-03-13Sale1,204.0$20.84
Canaan Partners X LLCTenPercentOwner2018-03-13Sale1,204.0$20.84
Liu David YChief Scientific Officer2018-03-12Sale3,500.0$21.29
Liu David YChief Scientific Officer2018-03-02Sale875.0$20.0
Liu David YChief Scientific Officer2018-01-16Sale875.0$20.0
Shames Richard S.Chief Medical Officer2017-12-22Sale3,529.0$20.5
PATEL DINESH V PH DPresident and CEO2017-12-21Sale8,210.0$19.56
PATEL DINESH V PH DPresident and CEO2017-12-20Sale1,790.0$19.55
Liu David YChief Scientific Officer2017-12-18Sale875.0$20.0
O'Neil Thomas P.Chief Financial Officer2017-12-18Sale8,000.0$20.0
Liu David YChief Scientific Officer2017-11-30Sale875.0$20.0
Liu David YChief Scientific Officer2017-11-13Sale3,500.0$16.97
Liu David YChief Scientific Officer2017-11-13Sale3,500.0$16.97
Shames Richard S.Chief Medical Officer2017-10-05Sale2,017.0$19.0
Shames Richard S.Chief Medical Officer2017-09-12Sale3,687.0$14.31
Shames Richard S.Chief Medical Officer2017-08-29Sale1,512.0$17.0
Liu David YChief Scientific Officer2017-08-28Sale3,500.0$15.0
Liu David YChief Scientific Officer2017-07-10Sale3,500.0$12.68
Giraudo BryanDirector2017-05-16Purchase10,000.0$6.46
JOHNSON & JOHNSONTenPercentOwner2016-08-16Purchase583,333.0$12.0
Johnson & Johnson Innovation - JJDC, Inc.TenPercentOwner2016-08-16Purchase583,333.0$12.0
Papanek JulieDirector2016-08-16Purchase583,333.0$12.0
CANAAN X L.P.Director,TenPercentOwner2016-08-16Purchase583,333.0$12.0
Canaan Partners X LLCDirector,TenPercentOwner2016-08-16Purchase583,333.0$12.0
Shanafelt ArmenDirector,TenPercentOwner2016-08-16Purchase583,333.0$12.0
Torres S. EdwardTenPercentOwner2016-08-16Purchase583,333.0$12.0
Lilly Ventures Fund I LLCTenPercentOwner2016-08-16Purchase583,333.0$12.0
Hall Steven EdwardTenPercentOwner2016-08-16Purchase583,333.0$12.0
LV Management Group, LLCTenPercentOwner2016-08-16Purchase583,333.0$12.0